BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 29738693)

  • 1. Cytochrome P450 1A1 (CYP1A1) Catalyzes Lipid Peroxidation of Oleic Acid-Induced HepG2 Cells.
    Huang B; Bao J; Cao YR; Gao HF; Jin Y
    Biochemistry (Mosc); 2018 May; 83(5):595-602. PubMed ID: 29738693
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytochrome P450 1A1 (CYP1A1) protects against nonalcoholic fatty liver disease caused by Western diet containing benzo[a]pyrene in mice.
    Uno S; Nebert DW; Makishima M
    Food Chem Toxicol; 2018 Mar; 113():73-82. PubMed ID: 29366871
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alpha-naphthoflavone attenuates non-alcoholic fatty liver disease in oleic acid-treated HepG2 hepatocytes and in high fat diet-fed mice.
    Xia H; Zhu X; Zhang X; Jiang H; Li B; Wang Z; Li D; Jin Y
    Biomed Pharmacother; 2019 Oct; 118():109287. PubMed ID: 31401392
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Suppressive effect of 1-nitropyrene on benzo[a]pyrene-induced CYP1A1 protein expression in HepG2 cells.
    Cherng SH; Hsu SL; Yang JL; Yu CT; Lee H
    Toxicol Lett; 2006 Mar; 161(3):236-43. PubMed ID: 16280210
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dioxin suppresses benzo[a]pyrene-induced mutations and DNA adduct formation through cytochrome P450 1A1 induction and (±)-anti-benzo[a]pyrene-7,8-diol-9,10-epoxide inactivation in human hepatoma cells.
    Shiizaki K; Kawanishi M; Yagi T
    Mutat Res; 2013 Jan; 750(1-2):77-85. PubMed ID: 23036853
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Arsenite down-regulates cytochrome P450 1A1 at the transcriptional and posttranslational levels in human HepG2 cells.
    Anwar-Mohamed A; El-Kadi AO
    Free Radic Biol Med; 2010 May; 48(10):1399-409. PubMed ID: 20188822
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The beneficial effects of resveratrol on steatosis and mitochondrial oxidative stress in HepG2 cells.
    Izdebska M; Piątkowska-Chmiel I; Korolczuk A; Herbet M; Gawrońska-Grzywacz M; Gieroba R; Sysa M; Czajkowska-Bania K; Cygal M; Korga A; Dudka J
    Can J Physiol Pharmacol; 2017 Dec; 95(12):1442-1453. PubMed ID: 28759727
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rutin exhibits hepatoprotective effects in a mouse model of non-alcoholic fatty liver disease by reducing hepatic lipid levels and mitigating lipid-induced oxidative injuries.
    Liu Q; Pan R; Ding L; Zhang F; Hu L; Ding B; Zhu L; Xia Y; Dou X
    Int Immunopharmacol; 2017 Aug; 49():132-141. PubMed ID: 28577437
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Down-regulation of cytochrome P450 1A1 by monomethylarsonous acid in human HepG2 cells.
    Elshenawy OH; Abdelhamid G; Soshilov AA; Denison MS; El-Kadi AO
    Toxicol Lett; 2017 Mar; 270():34-50. PubMed ID: 28189647
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transcriptional and posttranslational mechanisms modulating the expression of the cytochrome P450 1A1 gene by lead in HepG2 cells: a role of heme oxygenase.
    Korashy HM; El-Kadi AO
    Toxicology; 2012 Jan; 291(1-3):113-21. PubMed ID: 22120038
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 5-Methoxyflavone ameliorates non-alcoholic fatty liver disease through targeting the cytochrome P450 1A1.
    Zhang Y; Fu Q; Wu T; Liu K; Xiao Y; Liao Q; Qi X; Li Y; Zhou L
    Free Radic Biol Med; 2023 Feb; 195():178-191. PubMed ID: 36587922
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protective role of cytochrome P450 1A1 (CYP1A1) against benzo[a]pyrene-induced toxicity in mouse aorta.
    Uno S; Sakurai K; Nebert DW; Makishima M
    Toxicology; 2014 Feb; 316():34-42. PubMed ID: 24394547
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Benzo[g,h,i]perylene synergistically transactivates benzo[a]pyrene-induced CYP1A1 gene expression by aryl hydrocarbon receptor pathway.
    Cherng SH; Lin P; Yang JL; Hsu SL; Lee H
    Toxicol Appl Pharmacol; 2001 Jan; 170(1):63-8. PubMed ID: 11141357
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pregnane X receptor regulates the AhR/Cyp1A1 pathway and protects liver cells from benzo-[α]-pyrene-induced DNA damage.
    Cui H; Gu X; Chen J; Xie Y; Ke S; Wu J; Golovko A; Morpurgo B; Yan C; Phillips TD; Xie W; Luo J; Zhou Z; Tian Y
    Toxicol Lett; 2017 Jun; 275():67-76. PubMed ID: 28428138
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 5,7-Dimethoxyflavone downregulates CYP1A1 expression and benzo[a]pyrene-induced DNA binding in Hep G2 cells.
    Wen X; Walle UK; Walle T
    Carcinogenesis; 2005 Apr; 26(4):803-9. PubMed ID: 15661813
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel sesquiterpene glycoside from Loquat leaf alleviates oleic acid-induced steatosis and oxidative stress in HepG2 cells.
    Jian T; Wu Y; Ding X; Lv H; Ma L; Zuo Y; Ren B; Zhao L; Tong B; Chen J; Li W
    Biomed Pharmacother; 2018 Jan; 97():1125-1130. PubMed ID: 29136950
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Accumulation of lipids and oxidatively damaged DNA in hepatocytes exposed to particles.
    Vesterdal LK; Danielsen PH; Folkmann JK; Jespersen LF; Aguilar-Pelaez K; Roursgaard M; Loft S; Møller P
    Toxicol Appl Pharmacol; 2014 Jan; 274(2):350-60. PubMed ID: 24121055
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effect of metformin on mitochondrial pathway of apoptosis and oxidative stress in cell model of nonalcoholic fatty liver disease].
    Wu PB; Song Q; Yu YJ; Yu HG; Luo HS; Tan SY
    Zhonghua Gan Zang Bing Za Zhi; 2020 Jan; 28(1):64-68. PubMed ID: 32023702
    [No Abstract]   [Full Text] [Related]  

  • 19. Posttranslational mechanisms modulating the expression of the cytochrome P450 1A1 gene by methylmercury in HepG2 cells: a role of heme oxygenase-1.
    Amara IE; Anwar-Mohamed A; El-Kadi AO
    Toxicol Lett; 2013 Jun; 219(3):239-47. PubMed ID: 23541843
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ketoconazole Stereoisomers Differentially Induce Cytochrome P450 1A1 Between Human Hepatoma HepG2 and Mouse Hepatoma Hepa1c1c7 Cells.
    Anwar-Mohamed A; El-Sherbeni AA; Hamdy DA; Korashy HM; Brocks DR; El-Kadi AO
    J Pharm Sci; 2016 Mar; 105(3):1318-26. PubMed ID: 26886340
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.